Blog


 

An update on our malaria work for World Malaria Day 2024An update on our malaria work for World Malaria Day 2024

An update on our malaria work for World Malaria Day 2024

We’re using World Malaria Day to highlight our new part in the world’s ongoing efforts to eradicate malaria.

Posted on: 25 April 2024

A celebration of our partners for World Health Day 2024A celebration of our partners for World Health Day 2024

A celebration of our partners for World Health Day 2024

Sunday 7 April was World Health Day where we recognise the work being done to address global needs in health.

Posted on: 8 April 2024

World Tuberculosis Day 2024: An update of our work at CROIWorld Tuberculosis Day 2024: An update of our work at CROI

World Tuberculosis Day 2024: An update of our work at CROI

Every 24 March we commemorate World TB Day with the World Health Organisation. The theme for 2024 is ‘Yes! We can stop TB!’ and we wanted to update you on how we are playing our part in making that statement a reality.

Posted on: 22 March 2024

CELT celebrates Healthcare Science Week 2024 with Professor Saye KhooCELT celebrates Healthcare Science Week 2024 with Professor Saye Khoo

CELT celebrates Healthcare Science Week 2024 with Professor Saye Khoo

Healthcare Science Week is a week dedicated to celebrating the work of over fifty scientific specialisms and professional groups that make up the National Health Service’s diverse workforce.

Posted on: 15 March 2024

CELT Celebrates 2024's International Day of Women and Girls in ScienceCELT Celebrates 2024

CELT Celebrates 2024's International Day of Women and Girls in Science

Sunday 11 February was International Day of Women and Girls in Science. This day was implemented in 2015 by UNESCO and UN-Women to celebrate the critical contribution of women and girls to all fields of science and technology.

Posted on: 12 February 2024

The Long-acting Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum (LAMP) StudyThe Long-acting Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum (LAMP) Study

The Long-acting Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum (LAMP) Study

I’m Georgia Duffy, a PhD student in the Perinatal Pharmacology Group within the Centre of Excellence for Long-acting Therapeutics (CELT). I am being supervised by Dr Adeniyi Olagunju and my project is focused is Long-acting Antipsychotics for Mental Ill-health in Pregnancy and Postpartum (LAMP). My project is part of the LAMP study which is a multi-centre cohort study. Its overarching aim is to advance our understanding of the pharmacology of long-acting injectable antipsychotics (LAIA) during pregnancy and lactation.

Posted on: 12 May 2023

Invest, Innovate and Implement – How LONGEVITY can help deliver ZERO malariaInvest, Innovate and Implement – How LONGEVITY can help deliver ZERO malaria

Invest, Innovate and Implement – How LONGEVITY can help deliver ZERO malaria

World Malaria Day was established to provide education and understanding of malaria. Each year the Centre of Excellence for Long-acting Therapeutics (CELT) takes this opportunity to reaffirm our commitment to revolutionising malaria prevention and control to reduce the malaria burden in low- and middle-income countries (LMICs). The theme this year is “Time to deliver zero malaria: invest, innovate, implement” – Three aspects that are critical to our strategy to reduce the malaria burden.

Posted on: 24 April 2023

Fighting on the front-line – Empowering communities to drive long-acting injectable innovationFighting on the front-line – Empowering communities to drive long-acting injectable innovation

Fighting on the front-line – Empowering communities to drive long-acting injectable innovation

The latest WHO World Malaria Report indicates that Africa carries a disproportionately high burden of malaria with 95% of malaria cases and 96% of malaria deaths occurring in this region with children under 5 accounted for about 80% of all malaria deaths on the continent. It is now more important than ever that more investment in innovation and implementation of more effective prevention strategies for low- and middle-income countries.

Posted on: 24 April 2023

Dynamic partnerships for maximum impact: How our collaboration with Tandem Nano Ltd is fast-tracking our development programmeDynamic partnerships for maximum impact: How our collaboration with Tandem Nano Ltd is fast-tracking our development programme

Dynamic partnerships for maximum impact: How our collaboration with Tandem Nano Ltd is fast-tracking our development programme

Maintaining adherence to medication is often a huge challenge to patients in low- and middle-income countries (LMICs). Reasons for poor adherence can be quite complex. They may run out of tablets and are unable to get a new supply, they may forget to take their medicine or they simply don’t like taking tablets daily due to the difficult side effects they can cause. Regardless of the reason for poor adherence, there is overwhelming evidence that supports the need for a different approach to healthcare within affected communities.

Posted on: 5 April 2023

Blog